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INTRODUCTION 
 
 
The essential functions   of many organs in the body depend 
directly or indirectly on the liver. The haemopoietic system   is not an 
exception.  Beginning early in the foetal life, it exerts a profound 
influence on the formation and maintenance of blood.  Before  birth  it 
acts  as a haemopoietic  organ and after  birth it plays an active  and 
important  role in the production of many elements  necessary for 
homeostasis and haematopoiesis.  When the liver is damaged by either 
acute or chronic disease, the effect on these functions may be 
catastrophic.   
 
Liver plays a major role in carbohydrate metabolism, lipid 
metabolism and protein metabolism.  Its role in hematological 
manifestations is important.  Loss  of Liver  function  can manifest  as 
subtle  metabolic  abnormalities  and derangements in hematological  
parameters which can ultimately culminate  in grave  complications1.  
 
Liver plays a major role in maintaining the hematological 
parameters and maintain the homeostasis.  Liver is the storage site for 
iron vitamin B12 and folic acid which are necessary for the normal 
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 hematopoiesis2.  Liver also secretes the clotting factors and the inhibitors 
and keep the homeostasis in equilibrium.  
 
Chronic Liver disease is usually accompanied by hypersplenism2.  
Diminished erythrocyte survival is frequent.  In addition both 
parenchymal hepatic disease and cholestatic jaundice may produce blood 
coagulation defects. Dietary  deficiencies,  alcoholism,  bleeding and 
difficulties  in hepatic  synthesis  of proteins  used in blood  formation  or 
coagulation add to complexity  of the problem.  
 
Spontaneous  bleeding,  bruising  and purpura  together  with a 
history  of bleeding  after  minimal trauma such as venepuncture,  are 
most important  indications  of   bleeding  tendency in patients  with liver 
disease  than lab tests2.  
 
The hematological abnormalities in a chronic disease add 
morbidity to the primary pathology and increase the mortality.  Hence it 
becomes necessary to investigate the hematological abnormalities and 
haemostatic abnormalities to decrease the co morbidity.      
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 The study was conducted to assess the hematological abnormalities 
and haemostatic derangements and the nature of hematological 
abnormalities to reduce the morbidity.  Broadly the hematological 
abnormalities are viewed under:  
 
1. Abnormalities of formed element.        
a. RBCs  
b. WBCs 
c. Platelets 
 
2. Coagulation abnormalities:  
a. Impaired synthesis of clotting factors.  
b. Decreased inactivation of activated factors.  
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 AIM OF THE STUDY 
 
1. To study the hematological abnormalities in decompensated 
chronic liver disease patients.  
2. To find out the incidence and type of anaemia in chronic 
decompensated liver disease patients.  
3. To detect the abnormalities in RBCs WBC in cirrhotic patients.  
4. To detect platelet abnormalities.  
5. To assess the function of clotting factors in the patients with 
cirrhosis.  
6. To correlate the hematological findings with the severity of the 
disease.  
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 REVIEW OF LITERATURE 
 
LIVER 
 
Liver is one of the largest organs in the body.  It is the largest 
organ weighing about 1200 – 1500 gm, about one fifth of total adult 
body weight. Liver is divided into 8 functional segments by various 
planes2.  They are grouped in to 4 sectors.  Right anterior (V & VII), 
Left medial (IV) and left lateral with regard to portal, arterial supply 
and bile drainage2.  
 
FUNCTIONS OF LIVER3 
1. Formation  and secretion  of bile  
2. Secretion of plasma protein 
 Albumin  
 Fibrinogen   
 α 1- Antitrypsin 
 Ceruloplasmin 
 Haptoglobins 
 Transferrin 
 C3 component of complement  
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 3. Inactivation of various substances 
Toxins 
Steroids 
Hormones  
 4. Storage function 
Glycogen Storage  
Lipid Storage  
B12 and Folic acid storage              
Fat and water soluble vitamins 
5. Synthesis of Immuno globulins.  
 IgG, IgM, IgA 
6. Synthesis of Urea  
 
Cirrhosis of liver is characterized by irreversible chronic injury of 
the hepatocytes with extensive fibrosis and formation of regenerative 
nodules2. These  features  result from the hepatocytes necrosis,  collapse  
of the supporting  reticulum  network with subsequent connective  tissue 
deposition  distortion  of the vascular  bed,  and nodular regeneration  of 
the remaining  liver  parenchyma.  
 
The central event leading to hepatic fibrosis is activation of hepatic 
stellate cell. According to functional status of cirrhosis it may be 
compensated or decompensated cirrhosis.  
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 COMPENSATED CIRRHOSIS4  
Cirrhosis  discovered  at routine  examination  or biochemical 
reaction  with external  signs  and symptoms  of liver  failure like  nausea,  
vomiting, indigestion, flatulence,  dyspepsia, are early  features  in 
alcoholic  cirrhosis. It may be suspected in patients with vascular spiders, 
palmar erythema, unexplained epistaxis or edema of ankles.  
 
Clinically firm enlargement of liver and Splenomegaly may be 
present.  There will be a slight increase in serum transaminase or 
γ Glutamyl Transferase  level4.  
 
DECOMPENSATED CIRRHOSIS  
Signs of liver cell failure usually of ascites, jaundice are present in 
patients with Decompensated liver disease.  Continuous mild fever is 
often due to gram negative bacteremia, continuing hepatic cell necrosis or 
malignant transformation.  Jaundice implies liver cell destruction, 
exceeds the capacity for regeneration and is always  serious4.  
ETIOLOGICAL CLASSIFICATION OF CIRRHOSIS2  
1. Alcoholic  
2. Post necrotic or post infective HBV / HCV / HBV & HDV 
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 3. Metabolic  disorders  
a. Haemochromatosis  
b. Wilson's disease 
c. Alpha 1  antitrypsin deficiency  
d. Cystic  fibrosis  
e. Glycogen storage  disease 
f. Galactosemia  
g. Hereditary  fructose intolerance  
h. Hereditary  tyrosinemia  
i. Ornithine Trans carbomylase deficiency.  
j. Abetalipoproteinemia  
k. Porphyria  
4. Biliary tract  disease  
a. Extra  hepatic  biliary obstruction  
b. Intra hepatic  biliary  obstruction  
c. Primary biliary cirrhosis  
d. Primary sclerosing cholangitis.  
5. Venous  outflow  obstruction 
a. Veno occlusive disease 
b. Budd – chiari syndrome  
c. Cardiac failure 
6. Autoimmune chronic  liver disease  
7. Drugs  and toxins  
8. Other  Causes    
a. Obesity, diabetes  mellitus  
b. Intestinal bypass  
c. Sarcoidosis 
d. Indian  childhood cirrhosis  
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 Clinical manifestation in chronic liver disease is due to  
(i) Portal  hypertension  
(ii) Hepato cellular failure.  
 
FEATURES DUE TO PORTAL  HYPERTENSION5 
Splenomegaly   
Ascites 
Esophageal varices  
Anorectal Varies  
Dilated veins over abdomen.  
 
STIGMATA OF CHRONIC LIVER  DISEASE6   
Face  
Parotid enlargement  
Telengectasia  
Paper money skin 
Shrunken facies.  
 
Eyes  
Jaundice7 
Loss of eye brows 
Xanthelasma 
 
Trunk & abdomen 
Ascites 
Spider  angioma  
Loss of body hair.  
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 Hands   
Pallor  
Anemia  
White  nails  
Dupuytren's  contracture 
Palmar erythema  
Clubbing  
 
Skin  
Spider  naevi8 
Scanty body hair  
Slate grey pigmentation  
Scratch marks.  
Purpura, bruising.  
 
Nutrition  
Muscle wasting  
Glossitis  
Angular Stomatitis  
Anaemia  
 
Endocrine  
Gynaecomastia9  
Testicular atrophy  
Loss of Libido   
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 ROLE OF LIVER IN HEMATOPOIESIS AND 
HEMOSTASIS10 
 
 Liver plays an important role both in hematopoiesis and 
hemostasis. Thrombopoietin, a regulator of platelet synthesis is secreted 
by liver10,2.  Liver acts as a storage organ for vitamin B12 and folic acid 
which are necessary for the maturation of RBCS and WBCs. 
 
 Liver is one  of the primary  site of  reticulo endothelial system,  
contains plenty  of kupffer  cells,  plays an important  role in immunity  
and secretes  immunoglobulin2.  
 
 Liver plays a key role in B12 metabolism in taking part in 
enterohepaic circulation and also secretes transcobalamin I, necessary for 
the transport of B12 to the storage site. 
 
ROLE OF LIVER IN HEMOSTASIS 
 The role of liver in hemostasis is through the synthesis of 
Thrombopoietin, regulator of platelet production and synthesis of clotting 
factors.  Liver is also a site of synthesis of inhibitors of coagulation 
cascade and also the regulator of fibrinolysis. Thus liver is a key regulator 
of hemostasis11, 12.  
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  Where the vessel is injured, three haemostatic responses are 
initiated.  The response occur in stepwise pattern as   
1. The blood  vessel constricts 
2. Platelets adhere at the site of damage and aggregate. 
3. Fibrin clot is formed and modified.   
 
 First the blood vessel constricts, following which the platelets 
adhere aggregate and forms a temporary plug.  It is reinforced with a 
fibrin clot, through a coagulation cascade. The fibrin clot is modified and 
after tissue healing, it is dissolved by fibrinolytic components.  
CLOTTING FACTORS 
 Clotting factors are the key factors in coagulation cascade.  The 
summary of coagulation cascade is shown below.  
 
 Liver is the principal site of synthesis of all the coagulation protein 
with the exception of vWF and factor VIII C13. The proteins include.  
 
 Vitamin K dependent factors – II, VII, IX & X  
 Labile factor – V 
 Contact factor XI & VII  
 Fibrinogen and fibrin stabilizing factors.  
12 
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  Liver is the site of vitamin K storage.  The Vitamin K is essential 
for the synthesis of factors II, VII, IX and X. The function  of these  
blood  clotting  proteins depend  on the conversion  of glutamic  acid 
residues, post ribosomally  to γ  carboxy glutamic  acid by a carboxylase  
that requires  vitamin K.  
 
Inhibitors of coagulation cascade are also synthesized by the liver.  
These are Antithrombin III 
Protein C & S (Vitamin K dependent)  
Heparin cofactor II  
 
HEMATOLOGICAL ABNORMALITIES IN LIVER 
DISEASE ANAEMIA IN LIVER DISEASE14 
 
 Anaemia occurs in 75 % of patients with chronic liver disease. It is 
mostly of moderate severity and is either normochromic normocytic or 
moderately macrocytic in uncomplicated cirrhosis. If cirrhosis is 
complicated with hemorrhage or hemolysis then microcytic hypochromic 
anaemia can occur.  
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 Anaemia in uncomplicated cirrhosis is due to  
i. Hemodilution – due to increased plasma volume.  
ii. Shortened  red cell survival - hypersplenism  
iii. Reduced  bone  marrow  response  to anaemia  due to reduced  
erythropoietin level,  chronic  inflammation and increased  level  of 
inflammatory  cytokines suppressing  the bone marrow15.  
 
 Patients with cirrhosis have low oxygen – hemoglobin affinity 
which increases tissue oxygen availability, leading to better tolerance of 
anemia. 
 
PLASMA  VOLUME  
 Plasma volume is frequently increased in patients with cirrhosis 
especially with ascites. Hypervolemia causes low peripheral hemoglobin 
or erythrocyte  level16.  
 
LIVER DISEASE AND HEMATINIC METABOLISM       
IRON METABOLISM 
 Serum iron is bound to Beta globulin transferrin which is 
synthesized in liver.  Total iron binding capacity largely depends on the 
15 
 transferrin  concentration17. High total iron binding capacity indicates 
iron deficiency. Iron binding capacity is often lowered in patients with 
liver disease due to decreased synthesis of trasferrin. Serum transferrin 
receptor level is a more reliable lab index of iron deficiency in patients 
with liver disease.  
 
 Iron deficiency is also associated with hemorrhage and hemolysis.  
Iron deficiency causes microcytic hypochromic anaemia.  
 
 Low or normal serum iron concentration with a low or normal total 
iron binding capacity is frequently found in uncomplicated cirrhosis.  In 
alcohol induced liver diseases, alcohol has a toxic effect and suppresses 
the bone marrow18,19  but it increases  the iron  absorption from the GIT. 
Hepatic inflammation and necrosis tend to increase serum ferritin.  The 
rise in MCV which accompanies alcohol ingestion masks the iron 
deficiency.  
 
VITAMIN B12 AND FOLIC ACID METABOLISM  
 Intrinsic factor is required for B12 absorption and there is 
significant enterohepatic circulation. Pernicious anaemia is associated 
with primary biliary  cirrhosis20,21.  Alcohol inhibits  B12 absorption,  
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 elevated B12 binding capacity occurs in cirrhosis and hepatocellular 
carcinoma. Liver stores 5 -10 mg of vitamin B12 representing 50 – 90 % 
of body stores2.  
 
 Liver stores of folic acid are sufficient for only 4 to 5 months22,2. 
Alcohol induced liver disease and poor nutrition results in disordered 
folate metabolism. Hepatic  necrosis  leads  to increased  release  of folate  
from liver  and leads  to increased  urinary  excretion.  
 Altered  B12 and  folate metabolism causes  macrocytosis.  
 
HEMOLYTIC SYNDROMES IN LIVER  DISEASE  
 Recticulocytosis is frequently seen in liver disease patient.  Red  
cell life  span in reduced  by about 50 % in cirrhotics  with, the spleen  as 
the major  site of  destruction.  The  hemolysis may be due to 
 
1. Hypersplenism 
2. Lipid abnormalities.  
3. Hemolytic anaemia is also seen in Wilson’s disease and in 
autoimmune hepatitis (Coombs positive)22.  
4. Intracorpuscular defects such as instability of pyruvate kinase 
enzyme in alcoholic liver disease leads to hemolysis.  
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 ABNORMALITIES OF RED CELL SHAPE  
Microcytosis is due to Iron deficiency of various mechanisms in 
decompensated liver disease23.  
Macrocytosis is seen mostly in alcoholics 24,15. The increase in 
MCV is due to  
- Increase in RBC membrane cholesterol and phospholipid content.  
- Recticulocytosis associated with hemorrhage and hemolysis.  
- Abnormalities in B12 and Folic acid metabolism.  
- Intrinsic abnormality in bone marrow erythropoiesis.  
Target cells: bowel or saucer shaped thin macrocytes.It is seen in   
seen in most cases of hepato cellular failure   and cholestatic jaundice. 
Raised bile acids inhibit LCAT. So the red cell membrane LCAT is 
decreased resulting in loading of membrane with cholesterol and lecithin 
forms target cells 25  
 
Acanthocytosis: Seen in severe liver disease. It is a bad prognostic 
indicator.  Where it is associated with hemolytic anaemia it is called as 
spur cell anaemia26.  
 
Echinocytes: Speculated red cells due to changes in HDL in Liver 
disease patients.  
18 
 TABLE: 1 ABNORMALITY OF RBCs6 
 
Abnormality  Primary  liver 
disorders  
Disease  in other  systems  
Macrocytes  Many types of liver 
diseases  
Megaloblastic anaemia 
Hypothyroidism, cytotoxic drugs.  
Targets cells  Many types  of liver 
disease 
Thalassaemia  
Other haemoglobinopathies  
Hyposplenism,  e.g. SLE,  celiac 
disease  
Spherocytes  Zieve's  syndrome  Hereditary  spherocytosis  
Autoimmune haemolytic  anaemia 
Burns 
Echinocytes  
Acanthocytes  
Severe  chronic  liver  
disease  Very severe  
disease (especially  
alcoholic) (spur-cell 
anaemia)  
Haemolytic  anaemia   
Abetalipoproteinemia 
Anorexia nervosa / Malnutrition  
McLeod  phenotype 
Burr  cells Fragmented 
cells (schistocytes) 
Hepatorenal  syndrome Renal failure  
Thoromobotic  thromobocytopenic 
purpura,Microangiopathic  
haemolytic anaemia,  DIC,  HELLP  
syndrome some  
haemoglobinopathies  
Stomatocytes   
Tear – drop poikilocytes  
Alcoholic  cirrhosis  Alcoholism  
Haemolytic anaemias 
Primary and secondary  
myelofibrosis  
Nucleated  red cells  
punctuate  basophilla  
Acute fatty  liver of  
pregnancy  
Infections,  e.g.malaria 
Heavy metal poisoning  
Haemolytic / dyserythropoietic 
anaemia.  
Rouleaux  
Auto agglutination  
Sickle cells  
 Myeloma / macroglobulinemia / 
lymphoma Autoimmune haemolytic 
anaemia Sickle cell disease.  
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 WBC CHANGES IN LIVER DISEASE  
 Leukocytosis can occur in response to associated infection, 
hemorrhage, hemolysis and malignancy.  Eosinophilia in frequently seen 
in association   with parasitic disease, hepatocellular carcinoma, hepatic 
vein thrombosis, drug induced and also in primary biliary cirrhosis.  
 
 Leucopenia seen in Liver disease patients is due to hypersplenism27  
or a toxic effect on bone marrow (alcohol). Neutrophil function is 
affected by disturbance in late maturation of granulocyte differentiation. 
Chemotaxis is inhibited. There is a low level of complement C3 
 
 Hypergamma globulinemia is a well recognized feature of 
cirrhosis. It is initiated by immunization with enteric organisms normally 
filtered by liver.  IgG and IgA are markedly increased28.  There is 
generalized immunological hyperactivity. Benign  monoclonal  
gammopathy is associated  with primary  biliary  cirrhosis.  
 Specific Immunoglobulin’s are      
 IgA – Alcoholic cirrhosis  
 IgM – Primary biliary cirrhosis  
 IgG – Auto Immune Hepatitis.  
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 PLATELETS IN LIVER DISEASE  
   
 In decompensated liver disease patients, defects of platelet number 
and function are well documented. The mechanisms for 
thrombocytopenia  are29,30 :  
1. Shortened mean platelet life span. 
2. Platelet pooling in an enlarged  spleen31.  
3. Inability of marrow   to compensate.  
4. Reduced thrombopoietin  production32.  
5. Platelet associated immunoglobulin deficiency.  
 
 There  is no  clear  relationship  between  the abnormalities  of 
platelet kinetics  and the severity  of liver  disease  as very low platelet  
count often accompany portal  hypertension and  Splenomegaly  in 
patients  with relatively  normal liver function.  
 
 Normal platelets enriched with cholesterol show increased 
aggregability by ADP and adrenaline.  Platelets  in liver  disease  tend to 
be cholesterol  rich but  their aggregability is diminished,  probably  
because  the arachidonic  acid content  of platelet  phospholipids is 
reduced.  
21 
  Platelets from patients with cirrhosis also exhibit a defect in vWF 
binding domain. A raised  level  of platelet associated immunoglobulin  is 
found  in patients with decompensated liver disease such as  primary  
biliary  cirrhosis,  alcoholic  cirrhosis,  chronic  active  hepatitis.   
 
HEMOSTASIS IN CHRONIC LIVER DISEASE 
The abnormalities in hemostasis are due to  
i. Impaired synthesis of clotting factors.  
ii. Synthesis of abnormal clotting proteins.  
iii. Quantitative,  qualitative  platelet  defect  
iv. Enhanced  fibrinolytic  activity  
v. Disseminated intravascular coagulation12.  
 
DECREASED CLOTTING FACTOR LEVELS  
Factors II, VII, IX and X are vitamin K dependent clotting factors as 
well as the coagulation inhibitor Proteins C & S. Factor VII is usually 
first to be decreased due to its short half life .The non functional 
precursor forms of clotting factors are called proteins induced in vitamin 
K. absence (PIVKA).They are produced defective carboxylation in the 
presence of vitamin K deficiency. 
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 Factor V is synthesized in liver in the absence of vitamin K. Thus a 
decreased level of factor V associated with decreased levels of factor II, 
VII, IX and X is an indicator of hepatocellular insufficiency. 
Hypofibrinogenemia is less frequent, until there is severe liver damage. 
Factors XI, XII and high molecular weight kininogen are usually 
moderately decreased. Prekallikrein decreases early in  liver disease. 
Factor XIII, a fibrin stabilizing factor is also decreased 
  
DECREASED COAGULATION INHIBITORS 
Protein C, S also vitamin K dependent factors and antithrombin III 
are decreased in hepatocellular insufficiency34. The deficiency is not 
severe and usually parallels that of factor V. The synthesis is only 
affected by general damage to liver. Protein C deficiency parallels the 
deficiency of other vitamin K dependent factors. The level of protein S 
remains significantly greater due to extra hepatic source of protein S. 
 
Although levels of naturally occurring inhibitors of blood clotting 
are decreased in hepatocellular insufficiency clinical evidence of 
thrombo embolism is rarely noted. This is probably due to the balance 
maintained between these inhibitors and the procoagulant. 
23 
 Factors VIII is usually elevated in decompensated liver disease, 
which reflects extra hepatic synthesis associated with decreased 
catabolism by the diseased liver. But there is some abnormality in vWF 
binding domain35. 
 
FIBRINOGEN AND PROTHROMBIN 
Functional   abnormalities   of   fibrinogen   molecule   are   known   
as dysfibrinogenemias. Acquired dysfibrinogenemias are most often 
associated with Decompensated Liver disease. Defective polymerization 
results from an abnormal glycosylation of fibrinogen molecules55. An 
increased level of sialyl transferase has been demonstrated in liver 
patients with dysfibrinogenemias36. Impairment in fibrin formation 
results in prolonged thrombin time. Abnormal type of prothrorombin 
due to defective carboxylation in des-γ  -carboxy prothrorombin which 
is increased in chronic active hepatitis, cirrhosis and hepatocellular 
carcinoma. 
 
FIBRINOLYSIS 
In decompensated Liver disease patient, Enhanced fibrinolysis is 
due to decreased hepatic synthesis of inhibitors α 2-antiplasmin and 
24 
 plasminogen activator inhibitor as well as decreased clearance of tissue 
type plasminogen activator. 
DISSEMINATED INTRAVASCULAR COAGULATION 
DIC is due to the consequence of non compensated formation of 
thrombin and leads to the formation of platelet thrombi and fibrin within 
the circulation. Thus it is associated with activation and consumption of 
circulating platelets and consumption of factors V, VIII, VII, II & XIII 
Protein C & S, antithrombin III, plasminogen and α plasmin inhibitor37. 
 
The release of tissue thromboplastin like material by necrotic liver 
had been the triggering factor for DIC in severe liver failure. Increased 
fibrinopeptide - A levels have been found in patients with cirrhosis and 
chronic hepatitis. Elevated level of thrombin - anti thrombin complexes 
have been reported in chronic active hepatitis, decompensated liver 
disease, end stage liver disease and fulminant liver failure. 
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 TABLE-2 
COMBINATION OF HAEMATOLOGICAL ABNORMALITIES WITH6 
ABNORMAL LIVER FUNCTION TESTS 
Abnormality Haematological indices Primary liver disease Disease in other systems 
Red cell anaemia 
 
 
 
Increased MCV 
(macrocytic) 
Many liver diseases 
 
 
 
Alcoholism 
Vitamin B12/folate deficiency 
Haemolysis (reticulocytes up) 
 
 
 
 
 
 
 
Low MCV/MCHC 
(microcytic) 
Normochromic Normocytic
High reticulocyte count 
Low reticulocyte count 
 
 
With iron deficiency 
With  dilutional 
anaemia 
With hypersplenism 
With marrow aplasia 
(viral hepatitis) 
Thalassaemia 
Anaemia of chronic disease 
Haemolysis 
Paroxysmal nocturnal 
haemoglobinuria   (Budd- 
Chiari syndrome) 
 
Normal haemoglobin 
Erythrocytosis 
 
 
 
 
Increased MCV 
Low MCV 
 
 
 
 
Mild liver disease 
With iron deficiency 
Hepatocellular 
carcinoma 
Viral hepatitis (rare) 
Alcoholism 
Thalassaemia trait 
 
 
White cells 
 
 
 
 
 
 
 
Increased 
 
Neutrophils increased 
 
Lymphocytes increased 
Eosinophils increased 
 
 
 
 
 
With infection. 
neoplasia 
inflammation 
With    bacterial 
infection   or   steroid 
therapy 
Viral infections 
Parasitic infection 
Drug hepatitis 
Chronic    active 
hepatitis   (rare), 
sarcoidosis 
Myeloproliferative disorder 
Leukemia, Lymphoma, drugs  
 
Connective tissue disorders 
 
 
 
 
Monocytes  
Basophils/mast cells 
increased 
 
 
 
 
 
Tuberculosis, Leukemia, 
myeloprolifcrative disease 
mastocytosis 
 
 
 
 
 
Decreased 
 
 
 
With infection, 
marrow aplasia, or 
hyposplcnism 
Infections (typhoid, SBE, 
tuberculosis,  septicaemia) 
leukemia 
 Lymphocytes decreased  Viral infections 
 
 
 
 
Platelets 
 
 
 
 
Increased 
 
 
Decreased 
 
Liver   disease   and 
Hemorrhage. 
neoplasia 
inflammation 
With hypersplenism. 
viral hepatitis 
 
 
 
Myeloproliferativc disorder 
 
 
 
Lcukaemia/lymphoma 
Connective   tissue   disorders 
Paroxysmal              nocturnal  
hacmoglobinuria 
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 HAEMATOLOGICAL ABNORMALITIES IN 
DECOMPENSATED CHRONIC LIVER DISEASE2 
 
The Haemotological abnormalities in chronic liver disease add 
morbidity to the primary pathology and increase the mortality. The 
possible factors summarized as.   
 
Liver 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Acute liver  
diseases  
Chronic liver  
diseases 
Defective  
synthesis  
of proteins  
Defective  
storage  Vitamin 
B12 
Iron Folic  
Acid  
Expanded 
Plasma  
Volume  
Portal  
Hyperten
sion 
Splenome
galy 
Others 
Bleeding 
varices, 
piles, 
associated 
diseases  
Decreased  
coagulation  
factors  
Bleeding  
tendency  
Haemo- 
dilution  
Hyper- 
splenism 
Bleeding  
Anaemia  Thrombocy 
topenia
27 
  
 
 
 
 
 
 
Materials and Methods 
 DESIGN OF STUDY 
 
MATERIALS AND METHODS 
 
 
To assess the hematological abnormalities in chronic liver 
disease, the prevalence study was conducted in Coimbatore medical 
College Hospital during the period from Jan 2006 to June 2007. About 
50 patients were selected in for this study.  
 
All the cases included in the study were admitted in the hospital 
ward evaluated for chronic liver disease and the hematological 
abnormalities. Oral consent for the clinical examination and for the lab 
investigations were obtained from all patients. Written consent also 
obtained for the special procedure like upper GI endoscopy. 
 
All the patients were interrogated regarding their symptoms, 
duration of illness, bleeding tendencies, abdominal distension, 
jaundice, oliguria. Past history regarding previous treatment of 
diabetes, hypertension, tuberculosis, coronary heart disease, trauma, 
blood transfusion, surgery needle pricks, contact with blood products. 
28 
  
Personal history regarding alcoholism, smoking, high risk 
behavior also got. Family history of any liver disease was also noted. 
Then the entire patient was subjected to general examination and 
systemic examination. Patients were submitted to blood investigations.  
 
Patients were evaluated for chronic liver disease to establish the 
diagnosis of cirrhosis. In patients with defects in coagulation is 
evidenced by increased prothrombin time or decreased platelet count, 
had increased bleeding tendency during bone marrow biopsy.  
 
After    establishing    the    diagnosis    patients    were    evaluated    
for hematological abnormalities. All blood investigations regarding 
hematological profile were done in clinical pathology laboratory in 
Coimbatore medical College Hospital.  
 
 
Similarly prothrombin time and activated partial thromboplastin 
time were done at outside laboratory. 
 
 
 
29 
 TO ASSESS RBC ABNORMALITY 
 
1.       RBC count: 
 
RBC count was done with  Neubauer's chamber using Hayem's 
fluid or auto analyser13.  
Normal Value: 
1. Male 4- 5 to 5.9 x 106 mm3  
2. Female 4 to 5.2 x 106 mm3 
 
 
2.        Hemoglobin estimation: 
Done by Sahli's method, based on conversion of hemoglobin to 
acid hematin or acid analyzer. 
 Normal value: 
1. Male 13.5 to 17.5 gm % 
2. Female 12 to 16 gm %  
 
 
 
3.        Packed cell volume (PCV) 
 
It was done in autoanalyser or using microhematocrit capillary 
method.  
Normal value:  
1. Male 42 to 52 % 
2. Female 37 to 47 %  
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 4.       MCV, MCHC, MCH; 
 Were estimated by autoanalyser  
 (I) MCV = 
cummpermillioninRBC
PCVx10  
  80 – 97 FL – Normal 
  < 80- microcytic 
>97 – macrocytic 
 
(ii) MCH = )(10 Pg
cummpermillioninRBC
Hbx  
                      27 - 31 - N Normal 
< 27 – Hypo chromic 
> 31 - Hyper chromic 
 
 (iii) MCHC = (%)100
PCV
Hbx  
  32 – 36  %  - Normal` 
  < 32 Hypo chromic 
  > 36 – Hyper chromic  
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 5.        Peripheral smear for blood picture 
Using Leishmann's stain blood picture was examined with a lab 
microscope. 
(I) Low power field examination: 
-    Quality of film 
-   Number, distribution and staining of WBCs 
-    RBCs examination 
(ii) High power field examination: 
Assess RBC - Size, Shape, Hemoglobin concentration 
(iii) Oil immersion examination: 
Assess atypical cells and inclusion bodies 
 
6.       Reticulocyte count: 
Stain - 1% brilliant cresyl blue 
Normal – 0.2 – 2 % 
 
7. Bone narrow study (not conducted  in 23  patients  because of  
hemostatic abnormalities39,40.  
 
To assess WBC abnormality: 
1. Total WBC count 
Done by QBC method or using Neubauer's chamber with Turke's 
fluid  .Normal 4,500-11,000 cells per cmm17 
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 2. Differential  count  
 Assessed by QBC method or direct staining and visualizing 
with lab microscope. 
 
III. to Assess hemostasis  
1. Platelet count 
Manually was done by Rees Eecker method (staining with brilliant cresyl 
blue dye or by auto analyzer).  
Normal 1.5 to 3.5 x 105 / mm 3 
2. Prothrombin time:  
Done by Quick one stage method. Normal (10 – 14 sec).  
3. Bleeding time – By Ivy's method- Normal (1-7 mts) 
4. Clotting time   by lee & white method – Normal (5 -15 min) 
Activated partial thromboplastin time Normal (24 – 34 sec). 
 
IV. Liver function test  
In fifty cases, the following biochemical investigations were 
carried out to prove the presence and assess the severity of hepatocellular 
failure.  
1. Serum Proteins  Total Albumin 
  Differential Globulin  
 
2. Serum billirubin Total  Conjugated 
  Differential  Unconjugated  
 
3. Serum Alkaline phosphatase 
4. AST and ALT. 
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 V. UPPER GI ENDOSCOPY  
 UGI endoscopy was done at the medical gastroenterology 
department, after obtaining   patient's written consent. Patient was 
explained about the procedure, side effects.  Patients were kept on over 
night fasting. Upper GI endoscopy was correlated with other finding to 
establish the diagnosis.   
 
INCLUSION CRITERIA 
1. Adult patients presenting with signs and symptoms of chronic 
liver disease. 
EXCLUSION CRITERIA 
1. Acute liver cell failure 
2. Patients   with   known    GIT   malignancy   or   known   primary 
hepatocellular carcinoma. 
3. Patients with primary coagulation disorder, 
4. Liver cell failure due to infective cause like septicemia or end 
toxemia. 
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Observation and Results 
 DATA ANALYSIS 
 
This study regarding assessment of hematological profile and 
hemostasis was conducted among 50 inpatients in medicine department at 
Coimbatore Medical College Hospital.  
 
Out of 50 patients is this study, there are 40 male patients and 10 
female patients. The age of patients in this study was in the range from 20 
to 60. 
Table 3: Age of Patients 
Age in Yrs Male Female Total Percentage 
20 to 30 2 1 3 6 % 
30 to 40 13 5 18 36 % 
40 to 50  18 3 21 42 % 
50 to 60 7 1 8 16 % 
 
Most of the patients in the study were in the middle age group 
and only 6% were in younger age. Out of 3 patients one patient was 
diagnosed to have Wilson's disease and others were of unknown etiology. 
Remaining 47 patients were diagnosed as chronic decompensated liver 
disease with pathology as cirrhosis and were of variable etiology.  
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 AGE DISTRIBUTION OF CASES
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ALCOHOLISM 
Among 10 female patients, none gave history of alcoholism and 
among the 40 male patients 31 patients were found to be alcoholics. 
 
PAST HISTORY OF JAUNDICE  
Among 50 patients only 16 patients had past history of jaundice. 
Later serologic   investigations for HBV Ag. Anti HCV antibody showed 
6 patients positive for HBS Ag and only one shows positive for anti HCV 
antibody. 
While coming to data analysis of investigations, among the 50 
Chronic Liver Disease patient’s only 43 patients has raised billirubin 
level. About 7% of the patients were with normal billirubin level. 
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 COMMON CLINICAL SYMPTOMS
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NUMBER
Series1
ANALYSIS OF SYMPTOMS AND SIGNS 
 
TABLE - 4 
No. Symptom No. of cases % 
1. Weakness & Fatiguability  50 100 
2. Anorexia  50 100 
3. Nausea and / or vomiting  15 30 
4. Distension of abdomen  48 96 
5. Jaundice 30 60  
6. History of Bleeding Tendency   15 30 
 
 Among the 50 patients 100 % had anorexia and weakness 
Fatigability. Jaundice was found in 60 %. Bleeding tendency was 
observed in 30 % of them.    
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 ANALYSIS OF SIGNS:   
TABLE - 5 
No. SIGNS No. of cases % 
1. Anaemia  18 36 
2. Jaundice  30 60 
3. Pedal edema 29 58 
4. Arterial spiders  3 6 
5. Purpura & Bruises  4 8 
6. Gynecomastia and Testicular atrophy 5 10 
7. Dilated veins over abdomen 25 50 
8. Splenomegaly  26 52 
9. Ascites  48 96 
10. Asterixis 3 6 
18
30 29
3 4 5
2526
48
3
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CASES
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CLINICAL SIGNS
Anaemia 
Jaundice 
Pedal edema
Arterial spiders 
Purpura & Bruises 
Gynecomastia and
Testicular atrophy
Dilated veins over
abdomen
Splenomegaly
Ascites 
Asterixis
 
 Among the 50 patients 60 % had Jaundice and 36% had anemia. 
Splenomegaly observed in 52 %. Spiders and Asterixis are observed  
3 patients.  
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SIGNS OF LIVER CELL FAILURE 
 
 
 
 
JAUNDICE 
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SIGNS OF LIVER CELL FAILURE 
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 RBC COUNT IN CLD
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3 to 3.5
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> 4.5
ANALYSIS OF RBCS 
Patients in the study were analysed for the presence and absence of 
Anaemia and the characteristics of anaemia when present.   
 44 patients had anaemia and only six patients had normal 
hemoglobin above 12 gm%. About sixteen patients had severe anaemia 
less than 8 gm%. 
Table 6 ANEMIA IN CHRONIC LIVER DISEASE 
Haemoglobin gm % Cases Percentage 
< 6 2 2 % 
6 to 8 14 28 % 
8.1 to 10 22 44 % 
10.1 to 12 6 12 % 
12.1 to 18 6 12 % 
> 14 Nil   
 
Table 7 RBC COUNT IN CHRONIC LIVER DISEASE 
RBC Count Cases Percentage 
25 to 3 million / mm3 9 18 % 
3 to 3.5 14 28 % 
3.5 to 4 16 32 % 
4 to 4.5 5 10 % 
> 4.5 6 12 % 
 
 RBC COUNT IN CHRONIC LIVER DISEASE 
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 CHARACTERISTICS OF ANAEMIA 
All the twelve patients with normal hemoglobin level had 
normochromic and normocytic blood picture.  Among the 50 patients 26 
patients had normochromic and normocytic anaemia, 15 patients had 
microcytic anaemia and 8 patients had macrocytosis. Only one had 
dimorphic anaemia, patients with microcytic anaemia showed 
anisocytosis. And poikilocytosis. Target cells were seen in only two 
patients. Acanthocytes was not seen in any of the peripheral smears. 
Patients with macrocytosis had meant corpuscular volume more than  
97 fl. 
Table 8 Type of Anaemia  
Type of RBCs Patients with anaemia Percentage 
Normocytic  26 52 % 
Microcytic  15 30 % 
Macrocytic  8 16 % 
Dimorphic 1 2 % 
26
15
8
1
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5
10
15
20
25
30
Normocytic 
Microcytic 
Macrocytic 
Dimorphic
 
TYPE OF ANAEMIA 
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 BLOOD PICTURE 
 
 
 
MICROCYTIC HYPOCHROMIC ANAEMIA 
 
 
 
 
MACROCYTOSIS WITH HYPERSEGMENTED 
NEUTROPHILS 
 
 
 BLOOD PICTURE 
 
 
 
 
TARGET CELLS 
 
 
 
ACANTHOCYTES 
 
 WBC ABNORMALITIES  
 The analysis of WBCs was done with the total count and the 
differential count. The total count of WBCs range from 1050 / mm3 to 
16,100/mm3. Among the 50 patients Leukocytosis were observed in 11 
patients.  Eosinophilia was found in one patient.  Leukocytosis  were 
observed  in patients  with fever  due to secondary infection of Ascites 
due to repeated paracentesis  and four  patients  had Leukocytosis  due to  
spontaneous bacterial peritonitis. Leucopenia   was present in 6% of 
patients.  Lymphocytosis seen in 12 % of patients, Eosinophilia in 2 % of 
patients.  
Table 9 WBC COUNT IN CHRONIC LIVER DISEASE 
Total  count in Cells / 
mm3 No. of patients Percentage 
< 3000 3 6 % 
3000 – 6000 6 12 % 
6000 – 9000 16 32 % 
9000 – 12000 14 28 % 
 
 12, 000 
11 22 % 
WBC COUNT IN CLD
6%
12%
32%
28%
22%
< 3000
3000 – 6000
6000 – 9000
9000 – 12000
> 12, 000
 
WBC COUNT IN CHRONIC LIVER DISEASE  
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PLATELET  ABNORMALITIES 
 
Table 10 Platelet Count in Chronic Liver Disease 
 Total  count in Cells 
/ mm3 No. of patients Percentage 
< 50,000  4 8% 
50,000 – 1,00,000 6 12 % 
1 – 1.5 Lakhs  13 26 % 
1.5 – 2 lakhs 14 28 % 
>  2 lakhs 13 26 % 
 
PLATELET COUNT IN CLD
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Thrombocytopenia was found in 23 patients among 50 cases is the 
study. Severe thrombocytopenia  of < 50,000 cell / mm3 was found in 
patients  with large  spleen >8 cms  and had a history  of massive 
hemetemesis.  Thrombocytopenia  was associated  with history of atleast  
an episode of hematemesis.  Among the patients with severe 
thrombocytopenia 3 patients were found to have disseminated 
intravascular coagulation, later confirmed by the raised value of APTT 
and PT.  
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 Among the patients with normal level of platelets about 6 patients 
had history of atleast on episode of hematemesis.  Among  the 27 patients 
with normal  platelet  levels about  11 patients  had mild  Splenomegaly  
and 6 patients had moderate  Splenomegaly. In 5 patients Splenomegaly 
was observed in Ultra Sonogram only.  
 
SERUM PROTEINS 
Patients were analysed for the estimation of serum proteins, which 
is the synthetic function of the liver and evaluated for albumin globulin 
ratio which will be altered in the chronic liver disease patients. 
TABLE - 11: SERUM PROTEINS IN Chronic Liver Disease 
Total proteins gm% No of patients Percentage 
>6 7 14% 
6 to 5 21 42% 
5 to 4 21 42% 
<4 1 2 % 
 
Among patients only 14% had total proteins more than 6 gm% and 
only one patient had total protein <4 gm% and others in the middle group. 
42% had protein in the range of 6-5 gm% and 4% had 5-4 gm% proteins 
range. All the patients had albumin globulin ratio reversal, which is again, 
favours the diagnosis of Chronic Liver Disease.  
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 ABNORMALITIES IN COAGULATION  
The liver secretes all the clotting factor  except factor  VIII and 
VWF, As  we had no facility  for the  estimation of individual  clotting  
factors,  the patients were  assessed  for the coagulation  profile by testing  
for prothrombin  time and  activated  partial thromboplastin time.  Among 
the 50 patients 15 patients had prolonged prothrombin time and 35 
patients had normal prothrombin time.  There was no correlation between 
the severity of jaundice and the prolongation of prothrombin time.  
Among the 15 patients with prolonged prothrombin time about 8 
patients had history of atleast one episode of hemetemesis.  Bleeding time 
was  
TABLE – 12 - HEMOSTATIC PARAMETERS 
No Type of  change No. of cases % 
1. Platelet Count     
 Normal (>1.5 lakhs) 27 54 % 
 Low normal  (1-1.5 lakhs) 13 26 % 
 low (< 1 lakhs) 10 20 % 
2. Bleeding time   35 70 % 
 (1-7 mts) Normal  35 70 % 
  Prolonged  15 30 % 
3 Clotting time     
 (<15 mts) Normal  50 100 % 
  Prolonged 0 0.0 
4 Prothrombin time     
 (10-14 sec.)  Normal  35 70 % 
  Prolonged 15 30 % 
5. APTT (24-34 sec) Normal  47 94 % 
  Prolonged  3 6 % 
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 HEMOSTATIC PARAMETERS   
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Prolonged in 10 patients  who had  platelet  counts  less than 
1,00,000 / mm3 Bone marrow study  was not done  with the patients  with 
low platelet  count and prolonged prothromboin time due to the risk  of 
increased bleeding. 
Among the 50 patients APTT prolonged in 3 patients. It was 
significantly raised in patients with DIC.  They had history of 
spontaneous  bleeding  with internal bleeding and signs of endotoxemia.  
All the three had severe  thrombocytopenia with platelets < 50,000 / mm3 
Bone marrow biopsy was done in all patients  except those patients 
who had abnormal coagulation profile. Most of patients had 
normocellular bone  marrow and 22% patients had hyper cellularity. 
There was no hypoplasia and aplastic changes.  
 
 
45 
  
 
 
 
 
 
 
 
Discussion 
 DISCUSSION 
 
The study involving 50 patients done at Coimbatore Medical 
College Hospital has thrown light over the hematological abnormalities 
of chronic liver disease. The results of this study confirms with previous 
published reports.  
 
RBC ABNORMALITIES  
In the study we inferred that 88 % of the total patients had anemia 
and among them 32 % of cases had severe anemia.  
 
According to studies by Kimber C, Deller DJ and Lander H41. The 
mechanism of anemia in Chronic Liver Disease 1965 and sheehy w and 
Berman A, anemia occurs in upto 75 % of patients with chronic liver 
disease. It is characteristically of moderate severity and is either 
normochromic normocytic or moderately macrocytic.         
 
In our study 32% patient had severe anemia less than eight gm per 
cent. In uncomplicated cirrhosis it is rare to have such low level of 
hemoglobin as anemia in cirrhosis mostly due to. 
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 I. Hemodilution  
II. Decreased  erythropoietin level as per  the study  Siciliano 
Hepatol 1995 who showed  decreased  erythropoietin  level 
in cirrhosis  patients  with anemia when compared  with 
patients  with hypochromic anemia  due to iron deficiency.  
 
Cirrhosis without anemia is not associated with low 
erythropoietin levels (Pirsi, J Hepatol 1994)42. 
3. Chronic inflammation in cirrhosis suppresses the bone marrow.  
 
Anaemia state is further worsened by accompanying   
1. Bleeding esophageal varies.  
2. Bleeding peptic ulcer.  
3. Malignancy 
4. Bleeding anorectic varies. 
 
In developing countries like India, people with poor socio 
economic state already will have nutritional anemia due to iron deficiency 
and B12 and folic acid deficiency, which is superimposed with cirrhosis 
leading   to severe anemia.  Female patients had a greater proportion of 
severe anemia when compared with males. It shows the poor nutritional 
status of women in developing countries.  
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 Transferrin is the iron transport  protein43. The plasma is more than 
90 % saturated with iron in patients with untreated idiopathic 
hemochromatisis.  Reduced values may be found with cirrhosis.       
 
SERUM PROTEINS  
As per Tavill AS study fall in protein concentration usually reflect 
decreased hepatic synthesis44.  In our study 86 % of cases had decreased 
albumin and total protein level and all the 100% patients had albumin 
globulin ratio reversed. The hypoproteinemia  was also contributed  by 
poor socio economic  status  of the patients  who got admitted at  the 
government  hospitals.  
 
The mechanism for the low albumin level in cirrhosis is due to 
decreased synthetic function of liver. In cirrhosis there  is a chronic  
inflammatory4 process in progression  which causes elevated  cytokines  
level such as IL-1, IL-6, TNF-α inhibits the synthesis of albumin and 
transferrin . About 10 gm of albumin is synthesized by normal liver, 
where as with cirrhosis it synthesis only about 4 gms.  
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 CHARACTERISTICS OF ANEMIA  
 
According to James Dooley, Most common anemia seen in 
cirrhotic patients is normochromic and normocytic  anemia2. 
       
In our study most common anemia is normocytic, normochromic. 
The incidence of normochromic normocytic anemia in our patients is 52 
%. Where as in some studies there are varied results.  
 
According to study done by Malhotra45, 1951, the incidence of 
normocytic, normochromic anaemia was 90 %. In studies done by Bhatia 
(1961) and Mishra ET. al., (1982), the incidence were 59 % and 79 % 
respectively.  
 
In some studies such as Kimber C. ET. al., reported 43 % of 
macrocytosis, which was supported also by the study by Bingham et al. 
 
MACROCYTOSIS 
The incidence of macrocytosis in our patients was 16% 
macrocytosis in cirrhosis is mostly due to the toxic effect of alcohol on 
RBC production in the bone marrow and deficiency of B12 and folic 
acid46. Folic acid deficiency is also exacerbated with alcohol47 which was 
confirmed by the study done by Weir, Biochem, Pham 1985, and 
Lindenbaum48. 
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 MICROCYTOSIS  
About 30% patients in our group had microcytic hypo chromic 
anemia Bleeding from esophagi is, peptic  ulceration or esophageal 
varies, compounded by the haemostatic defects of chronic liver disease, 
occurs in upto 70% of patients with Liver disease as per the study 
conducted by Kimber, Philips, et al., macrocytosis in cirrhosis is  due to :    
i. Decreased total iron concentration with alterations in iron 
metabolism due to decreased to serum transferrin.  
ii. Hemolytic due to hypersplenism, autoimmune process, Lipid 
abnormalities or intra corpuscular defects. 
The Total Iron binding capacity BC is often lowered in cirrhosis 
due to reduced hepatic synthesis of transferrin. 
 
ABNORMALITIES OF WBCs 
 
In our study group all the 50 patients WBC total count are in the 
range of 1000-16,000 cell per mm3. About 11 patients  had Leukocytosis  
which  was mostly  due to infections  due to community  acquired  
infections,  nosocomial infection, spontaneous  bacterial peritonitis  and 
secondary peritonitis due to repeated peritoneal paracentesis.  
 
In our study group in patients with Leukocytosis >12,000 / mm3 of 
blood most of the patients had history of repeated hospital admissions 
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 and had repeated paracentesis. About 50 % of patients with Leukocytosis 
and high grade fever and all patients with Leukocytosis had increased cell 
count mostly of polymorphs in ascetic fluid analysis, which suggests the 
presence of peritonitis in this group of patients. Spontaneous bacterial 
peritonitis is one of the important causes of Leucocytosis17.  
 
Leucopenia present in 6 % of the patients may be due to  
 
i. Direct influences of alcohol on bone marrow.  
ii. Chronic inflammatory cytokines having suppressor effect on 
bone marrow.  
iii. Hyposplenism 
iv. Infection.  
 
Eosinophilia is seen in association with parasitic disease and also 
associated with Hepatic vein thrombosis, hepatocellular carcinoma, and 
drug allergy and graft rejection.  It is also found in primary biliary 
cirrhosis. Serum Eosinophilia cationic protein was high in patients with 
primary biliary cirrhosis. Eosinophilia is present in 2% of cases in our 
study group mostly due to parasitic infection.  
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 IMMUNOGLOBULINS AND LIVER DISEASE 
As per the studies  Feizi Gut 1968 and Jensen Arch Int Med. 198249 
and Jensen Arch  Int Med. 1982 it has  been proved  that 
Hyperglobulinemia is a well recognized features of cirrhosis. It has been 
suggested that this polyclonal  hypergamaglobulinemia is initiated  by 
immunization with enteric organisms normally filtered by the Liver.  
 
Cirrhosis may be associated with a  state generalized hyperactivity, 
perhaps as a result of a defect  of immune  regulation.  Peripheral blood 
mononuclear cells from cirrhosis with hypergamaglobulinemia had a 
normal proportion of B cells but that IgG and IgA 
hypergamaglobulinemia synthesis was markedly increased.  
 
In our study almost all patients had hypergamaglobulinemia and all 
the 100 % cases had albumin globulin ratio reversal.  The ratio reversal is 
also contributed by lower albumin concentration due to decreased 
synthesis.  
 
PLATELETS ABNORMALITIES  
Defects of platelet number and function are well documented   in 
patients with chronic liver disease contributing significantly to their 
hemostatic abnormalities. Alcoholic  liver  disease  is associated with 
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 additional  abnormalities which  are probably  a consequence  of the toxic 
effect  of alcohol  on platelet  production  and function  as proved by the 
studies by Mikhandes BMJ, 1986, Hilbom BMJ 198750.                  
 
Causes for thrombocytopenia are : 
i. Shortened life span 
ii. Platelet pooling in an enlarged spleen51 
iii. Inability of bone marrow to compensate 
iv. Reduced thrombopoietin level 
 In our study the above findings are evident and out of 50 patients 
10 patients had thrombocytopenia < 1,00,000 / mm3 and 13 patients had  
mild thrombocytopenia( 1 – 1.5 lakhs / mm3). All the patients with count 
less than one lakhs had history of  bleeding tendencies and among them 
two patients were diagnosed to have DIC, which also contributed to the 
very low platelet count in cirrhotic. All the patients with platelet count 
less than one lakhs had increased bleeding time.  
 
ABNORMALITIES IN HEMOSTASIS 
 Liver plays a major role in regulating hemostasis, synthesizing 
most of the clotting factors and coagulation inhibitors52, 56, as well as 
some proteins of the fibrinolytic activated enzymes of the clotting and of 
the fibrinolytic system57, 58. 
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The contributing factors are   
1. Defective synthesis of coagulation factors 
2. Thrombocytopenia  
3. Increased fibrinolytic activity  
4. Intravascular coagulation. 
As per the studies Manner Ej, 1992 and Colman RW and Rubies 
R.N. blood coagulation 198853, clotting factors may be decreased even 
before any other evidence of liver damage54, 59. In hepatic cellular failure 
factor VII is earlier to be decreased due to its short half life then followed 
by factors II and X. Factor IX is usually the last to be affected. 
 
 These are vitamins K dependant proteins synthesized in Liver. If 
these deficiencies are unresponsive to parenteral administration of 
vitamin K, it can be assumed that the hepatic synthesis of clotting factors 
is impaired. 
 
PROTHROMBIN TIME ABNORMALITIES 
 In our study 15 patients had elevated prothrombin value which is 
evidence of clotting factor deficiency. They were treated with vitamin K 
injection for a period of one week and the prothrombin time was 
repeated. Some showed decrease in the prothrombin value  
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 APTT ABNORMAILITY    
 APTT is prolonged in all coagulation defects including platelet 
activity and thromoboplastin. Prolonged APTT is found in to:  
1. Vitamin K deficiency  
2. Liver disease55 
3. Presence of circulating anticoagulants.  
4. Disseminated Intra vascular coagulation  
 
In our study three patients had DIC and they had significant 
prolongation in APTT along with increased PT with severe 
thrombocytopenia.  Other patients with history of bleeding tendencies 
were found to have moderately increased APTT.     
 
According to James Dooley APTT may be found to be moderate to 
highly prolonged according to the degree of liver  failure2. In case of 
moderate  deficiencies  of factor II, IX, X  and V, associated  with a high  
level of factor  VIII and APTT will be normal.60 
 
DISSEMINATED INTRAVASCULAR COAGULATION  
In our study 3 patients were found to have DIC and it was 
confirmed with prologation of PT and APTT along with severe 
thrombocytopenia and was confirmed by estimation of D-dimer. These 
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 patients were found to have septicemia, and they are culture positive 
showing gram negative organisms.  
 
Thus with the above studies we inferred that many of the 
haematological abnormalities are to be noticed in a chronic liver 
disease patient, so that the co morbidity which may reduce the mortality  
From the above study we noted that the presence of severe 
anemia does not correlate with severity of disease as evident by normal 
serum billirubin and hypoalbuminemia. Instead it is related with history 
of bleeding tendency.  
The character of anemia depends upon the various factors such as 
bleeding tendencies, dietary deficiency, alcoholism, But normochromic 
normocytic anemia is most commonly found and mostly due to the 
primary pathology like hemodilution and chronic inflammation 
suppressing the bone marrow. The Leukocytosis is associated with 
infections mostly of secondary peritonitis due to repeated paracentesis 
and spontaneous bacterial peritonitis. 
 
 
56 
 Platelet abnormalities as assessed by Thrombocytopenia and 
increased bleeding time had no correlation with the severity of liver cell 
failure best associated in patients with large spleen and is more common 
in patients with bleeding tendencies. 
Similarly prothrombin time and APTT are prolonged. This is 
correlated with the liver disease and there is significant rise in APTT 
along with severe thrombocytopenia is seen in patients with DIC.     
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Summary 
 
 SUMMARY 
50 patients of   decompensated   chronic   liver   disease   patients  
were studied. 
 
1. Almost 80% of the patients had anemia in any one of the form. 
2. Most common anaemia in cirrhosis is normochromic normocytic 
anemia as inferred from the study (52 %). 
3. Microcytic anaemia is found in 30%  of studied population   
4. Macrocytosis (16%) is almost common with alcoholics. 
5. Abnormal red cells such as microcytic, microcytic, target cells, 
anisocytosis are found to be common in cirrhosis. 
6. Leucopenia (6%) is found to be rare as per the study and 
Leukocytosis is more common in patients with spontaneous bacterial 
peritonitis and secondary peritonitis. 
7. Thrombocytopenia is present is more than 30% of patients and is 
commonly present in the patients with Splenomegaly and with the 
history of bleeding tendencies. 
8. Prothrombin time prolonged in 46% of the patients. A significant 
rise in APTT with severe thrombocytopenia is found is DIC patients. 
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Conclusion  
  
CONCLUSION  
 
1. The most common anemia in cirrhotics is normochromic 
normocytic anemia. Microcytosis occur in patients with bleeding 
tendencies and macrocytosis occurs mostly in alcoholics. 
 
2. Leucopenia occurs in a small fraction of patients and Leukocytosis 
occurs in patients with history of repeated paracentesis and 
peritonitis. Eosinophilia is associated with parasitic infections. 
 
3. Thrombocytopenia is present in most of the cirrhosis patients and is 
associated with increased bleeding tendencies. 
 
4.  Increased prothrombin time and APTT due to decreased synthesis 
of clotting factors. 
 
5. All the cirrhosis patients must be evaluated for hematological and 
haemostatic abnormalities. Early treatment to correct these co 
morbidities can decrease the mortality. 
 
59 
  
 
 
 
 
 
 
 
Bibliography 
 BIBLIOGRAPHY 
 
1. Marc. Ghany, Jay H. Hoofnagle ;approach to liver disease 16th 
Edition Harrison principle of Internal Medicine volume 2, 1808 – 
1813, 1855 – 58 
2. James Dooley ;Sheila Sherlock, Disease of the liver and biliary 
system Eleventh Edition 4; 47, 22, 364 – 381. 
3. Jacquelyn J Mahar ;Sleisenger & Furdtran's Gastrointestinal and 
liver disease Sixth Edition 71,  1199. 
4. Conn D A H enbury E;  Schiff's Disease of The liver ,Nineth 
Edition Volume two, 2003, 625 – 640. 
5. R.W. Chapman, J.D. Collier, PC Hayes Davidson's Principle and 
Practice of Medicine 20th Edition 954- 962. 
6. Vincent G Bain ;Oxford Text Book of Medicine fourth Edition, 
Volume One P 667-74. 508- 512. 
7. Summer skill WHJ, Molnar GD, Eye Signs in Hepatic cirrhosis ; 
New England Journal of Medicine 1982; 266; 1244. 
8. Pirovino M, Linder R, Boss C et al, cutaneous spider Nevi in Liver 
Cirrhosis; Hormonal investigations Klin. wochenschr 1988; 62 : 
298. 
60 
 9. Lioyd CW, Williams RH. Endocrine Changes associated with 
cirrhosis of liver American Journal of medicine 1998 :  4: 315. 
10. Goldman, Ausiello ; Cecil Text Book of Medicine twenty second 
edition, P.936 – 942. 
11. Paramo JA, Rocha E. Hemostasis in advanced liver disease semin. 
Thromb, Hemost 1993, 19 : 184. 
12. Hemostasis in chronic liver disease -LISMAN, T.; CALDWELL, 
S. H.; LEEBEEK, F. W. G.; PORTE, R. J. Journal of Thrombosis 
and Haemostasis, Volume 4, Number 9, September 2006 , pp. 
2059-2060(2) 
13. Shirley Parker Lovine; Maxwell M. Wintrobe clinical 
Haematology,Eleventh Edition,P 1603. 
14. Jandl, James H. The Anemia Of Liver Disease: Observations On 
Its Mechanism . J Clin Invest. 1995 Mar;34(3):390–404. 
15. Eichner, E.R., and Hillman, R.S. 1971. The evolution of anemia in 
alcoholic patients.American Journal of Medicine 50:218-32.' 
16. Tadataka, Yamada Text book of Gastroennology Fourth Edition 
Volume Two, P  2415- 50. 
17. G.C. De Gruchy, Clinical Haematology in medical Practice 4th 
Ediction Chap 6 318. 
61 
 18. Lindenbaum J, Lieber CS. Hematologic effects of alcohol in man 
in the absence of nutritional deficiency. N Engl J Med. 1989 Aug 
14;281(7):333–338 
19. Study of haematological profile in chronic alcoholism KK Samal, 
BL Parija, PK Hui, SK Tripathy, K Nayak, S Mishra, SR Pattanaik, 
A Viswabandya - MKVH, Medical College, Berhampur. 
20. Wu A, Chanarin I, Slavin G, Levi AJ. Folate deficiency in the 
alcoholic--its relationship to clinical and haematological 
abnormalities, liver disease and folate stores. Br J Haematol. 1975 
Mar;29(3):469–478 
21. Hines JD. Reversible megaloblastic and sideroblastic marrow 
abnormalities in alcoholic patients. Br J Haematol. 1969 16(1):87–
101.Jan–Feb; 
22. Klipstein F.A. et al (1965) Folate deficiency cirrhosis of liver, 
blood 25, 443. 
23.  Zieve L. Hemolytic anaemia in liver disease medicine (Baltimore) 
1996; 45 ; 497. 
24. Bringham J (1960) The macrocytosis of Hepatic disease thick 
macrocytes Blood 14, 144, 494. 
 
 
61 
 25. Richard A Cooper et al (1975) An analysis of lipoproteins, bile 
acids and red cell membranes associated with target cells and the 
spur cells in patients with cirrhosis of liver.  
26. Smith ja, Lonergan et, Sterling k. Spur-cell anemia: acanthocytes in 
alcoholic cirrhosis. N ENGL J MED. 1994 AUG 20;271:396–398. 
27. Mc Cormick PA. The spleen, hypersplenism, and other 
relationships between the liver and spleen. In: Bircher J,  
Benhamou J-P, McIntyre N, Rizzetto M, Rodés J, editors. Oxford 
textbook of clinical hepatology. Oxford: Oxford University Press 
1999; 787-795. 
28. Vande weil A, Delacroix DL,  Van Hattum J. et al. Characteristic 
of serum Immunoglobulin IgA in alcoholic liver disease.  
29. Younger H.M, Hadoke PWF, Dillion JF et al, Platelet function in 
Cirrhosis and the role of Humoral factors. Eur. J. Gastrontrol 
Hepatol 1997 9. 989. 
30. Lindenbaum J, Hargrove RL. Thrombocytopenia in alcoholics. 
Ann Intern Med. 1968 Mar;68(3):526–532 
31. Laffi G Marra F, Gressele P et. al, Evidence for a storage pool 
defect in platelets from Cirrhosis patients with defective 
aggregation gastroenterology 1992. 103; 641. 
32. Goulis J, Chau TN, Jordan S, Mehta AB, Watkinson A, Rolles K, 
Burroughs AK. Thrombopoietin concentrations are low in patients 
with cirrhosis and thrombocytopenia .Gut 1999; 44: 754- 758 
62 
 33. Expression of factor VII in the liver of patients with liver disease: 
correlations with the disease severity and impairment in the 
hemostasis. -Blood Coagulation & Fibrinolysis. 12(3):193-199, 
April 2001.  
34. Mammen EF Coagulation defects in Liver disease  Med Clin North 
Am 1994 78 : 545. 
35. Richard N Mitchell, Robins and Cotron Seventh Edition 
Homeostasis – Von Willi Brand factor 126 – 129. 
36. Leebeak FWG, Kluft C, Knot EAR et al, A shift in balance 
between profibrinolytic and a fibrinolytic factors  causes enhanced 
fihrinolysis in cirrhosis Gastroentrology 1991 ; 101 : 1382. 
37. Bakker CM, Knot KAR, Stibbe, J et al, Disseminated Intra 
vascular coagulation in liver disease J. Hepatol. 1992; 15 : 330. 
38. Schalm SW. The diagnosis of cirrhosis J. Hepatol 1997; 27: 118. 
39. Jacobson D.S. et. al, The blood and bone marrow in patients with 
cirrhosis of Liver (1989). 
40. Jerrold et al (1999) Haematological observation in patients with 
chronic Hepatic insufficiency sternal bone marrow morphology.      
41. Kimberc, Deller DJ and Lander H mechanism of anaemia in 
cirrhosis 1985. 
42. Prisi, J Hepatol (1994)  Correlation of Anaemia in cirrhosis with 
Erythropoitein.  
63 
 43. Fletcher LM Halliday JW Powel LW Interrelationship  of alcohol 
and Iron in liver disease with  reference to the Iron binding to 
protein, ferritin Transferrin. J. Gastro entrol. Hepatol. 1999; 14 : 
202. 
44. Tavill AS (1969) Fall in protein concentration albumin globulin 
ratio and liver disease.  
45. Bhatia (1961) incidence of anaemia and characteristic in liver 
disease.  
46. Jolliffe, N., and Jellinek, E.M. 1941. Vitamin deficiencies and liver 
cirrhosis in alcoholism. VII. Cirrhosis of the liver. Quarterly 
Journal of Studies on Alcohol 2:544-83. Jolliffe, N.; Bowman, 
K.M.; Rosenblum, L.A.; and Fein, H.D. 1940. 
47. Vitamins and alcoholism. II. Folate and vitamin B1z. International 
Journal for Vitamin Nutrition Research 5096-12 1. 
48. Weir, Biochan, Pharm and Lindenbaum (1988) Alchohol and folate 
deficiency.  
49. Jansen Arch Internal  Medicine  (1982) Hyperglobulinemia and 
cirrhosis.  
50. Mikhandes, BMJ, 1986 Hilbom BMJ 1957 Effect of Alcohol on 
platelets.  
 
 
64 
 51. Aster R.H. (1966) et. al, Pooling of platelet in the  spleen. Role of 
platelets in the Pathogenesis of Hypersplenism – thrombocytopenia 
Journal of clinical investigations 45, 645. 
52. Hodenberg L et al (1972) Tests of hemostastic mechanism in 
cirrhosis of liver and their diagnostic significance.  
53. Colman RW and Rubber RN Blood coagulation 1958 clotting 
factors and  liver damage.  
54. Thalmeir U ,Triantos CKssmonakis DN,patch D Burough A.K . 
Coagulation and Vaiceal bleeding in cirrhosis GUT 2005;54;556-
63 
55. Blake JC, sprengers D, Grech pot all Activated partial 
thromoboplastin time and bleeding time in patients with Hepatic 
cirrhosis. Br. Med. J. 1990 ; 301 : 12.  
56. European Journal of Gastroenterology & Hepatology. 15(4):433-
435, April 2003. Shawcross, Debbie L; Mookerjee, Rajeshwar P; 
Jalan, Rajivs. 
57. Mehta AB , MC Intyren N,Haematological disorders  in liver 
disease .Trends Exptl clinical medicine 1998;8;8 -25 
` 
 
65 
 58.  Alterations in Blood Parameters in Patients with Liver Cirrhosis 
and Ascites Konstantinos Charalabopoulos, Dimitrios Peschos, 
Leonidas Zoganas,   
59. SueCampbell;Haematological alterations in liver 
diseases,WilliamsHematology,Seventhdition,564-66 
60. Bernsterin DE, Jeffers L, Erhardsten E at el, prothrombin time 
cirrhotic patients, a preliminary study Gastroentrology 1997' 113 : 
1930. 
 
 
 
 
 
 
 
 
 
 
 
66 
  
 
 
 
 
 
 
Appendix  
  
 
 
 
 
 
 
Proforma 
 PROFORMA 
 
Name : Age : Sex : 
IP No : Occupation : D.O.A : 
  D. O.D :  
Presenting Compliants of : 
History of  Present Illness : 
 Nausea / Anorexia 
 Vomiting 
 Haematemesis / Malena 
 Swelling of Legs / Oliguria 
 Jaundice / Abd. pain 
 Loss of Wt / Appetite 
Past History :   
 Jaundice Blood Transfusion Surgery 
 TB Diabetes      Needle Prick GI Bleed 
Personal History:  
 Smoking  Alcohols        Other 
Family History :  
 
General Examination  
Anemia  Jaundice  
Pedal Edema Lymphadenopathy  
Pulse rate BP Signs of Liver Cell failure  
 
Examination of the Abdomen 
Inspection 
Palpation 
Percussion 
Auscultation 
Examination of other systems 
 CVS RS CNS 
67 
 Investigations  
1. Hematological 
RBC  MCH Peripheral Smear 
Hb  MCHC 
TLC  MCV 
DLC  PCV 
 
2. Liver Function Test  
Serum Bilirubin – Total / Direct / indirect   
Serum Protein – Total Albumin Globulin 
SGOT/ PT  
Alkaline Phosphatase 
Ascitic Fluid Analysis – Cell count / Bio chemical  
 
3.  Coagulation profile  
 BT PT 
 PT APTT 
 
4. Bone marrow study 
5. Ultrasonogram Abdomen 
6. Upper GI Endoscopy 
7. Other Investigations 
 Blood Sugar / Urea  
 Serum Creatinine 
 Urine Albumin/ Sugar/ Deposit 
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Master Chart 
 
 ABBREVIATIONS IN MASTER CHART 
BT - Bleeding Time  
CT - Clotting Time  
PT - Prothrombin Time  
APTT - Activated Partial thromoboplastin time  
MCH - Mean Corpuscular Hemoglobin 
MCHC - Mean Corpuscular Hemoglobin Concentration  
MCV - Mean Corpuscular Volume 
PCV - Packed cell volume 
UGD - Upper Gastro duodenal Endoscopy  
LFT - Liver function test 
AST - Aspartate transaminase 
ALT - Alanine transminase 
SAP - Serum Alkaline Phosphatase 
M - Male 
F - Female 
+ - Present 
- - Absent 
T - Total 
A - Albumin 
G - Globulin 
D - Direct 
I - Indirect 
Mod - Moderate 
 
 
 
 
  
  
  
  
 
 
  
 
  
  
 
 
